학술논문

A phase III study comparing BCD-021, a bevacizumab biosimilar, and reference bevacizumab in patients with stage IIIB or IV non-squamous NSCLC
Document Type
Journal
Source
ANNALS OF ONCOLOGY; 2021, 32 pS1022-pS1022, 1p. Supplement: 5
Subject
Language
English
ISSN
15698041